Spindletop Health Acquisition Corp. Unit
SHCAU
SHCAU was delisted on the 27th of December, 2022.
12 hedge funds and large institutions have $23.9M invested in Spindletop Health Acquisition Corp. Unit in 2022 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 3 reducing their positions, and 8 closing their positions.
18% less capital invested
Capital invested by funds: $29.3M → $23.9M (-$5.4M)
40% less funds holding
Funds holding: 20 → 12 (-8)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 8
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 3
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MP
Mangrove Partners
Greenwich,
Connecticut
|
-$2.01M |
| 2 |
MF
Magnetar Financial
Evanston,
Illinois
|
-$899K |
| 3 |
CM
Cohanzick Management
Pleasantville,
New York
|
-$652K |
| 4 |
CSS
Cubist Systematic Strategies
Stamford,
Connecticut
|
-$647K |
| 5 |
State of Wisconsin Investment Board
Madison,
Wisconsin
|
-$502K |
SHCAU Hedge Fund Activity: Q2 2022 in Review
12 of the 5,959 institutional investors tracked by Wall St. Rank reported a position in Spindletop Health Acquisition Corp. Unit (SHCAU) for Q2 2022, worth a combined $23.9M — down 18% from $29.3M a quarter earlier.
Sellers outnumbered buyers: 8 funds closed out of SHCAU and 0 opened new positions — a net loss of 8 holders — while 3 trimmed existing stakes and 0 added.
The largest seller was Mangrove Partners, exiting entirely with an estimated $2.01M sold.
- 12 institutional investors held Spindletop Health Acquisition Corp. Unit (SHCAU) as of Q2 2022, down from 20 in Q1 2022.
- Funds reported $23.9M of Spindletop Health Acquisition Corp. Unit stock for Q2 2022, down 18% quarter-over-quarter.
- 0 funds opened new Spindletop Health Acquisition Corp. Unit positions in Q2 2022 and 8 closed out, a net change of -8 holders.
- The largest Spindletop Health Acquisition Corp. Unit seller in Q2 2022 was Mangrove Partners, an estimated $2.01M sold.
Based on aggregated 13F filings for Q2 2022.